levocetirizine dihydrochloride
- Product NDC
- 70934-835
- 11-digit product format
- 709340835
- Labeler code
- 70934
- Product ID
- 70934-835_bd0be5ab-0f12-9015-e053-2995a90a0f87
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- levocetirizine dihydrochloride
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Denton Pharma, Inc. DBA Northwind Pharmaceuticals
- Application
- ANDA203646
- Marketing category
- ANDA
- Marketing start
- 2021-03-05
- Marketing end
- 0000-00-00
- Substance
- LEVOCETIRIZINE DIHYDROCHLORIDE
- Active strength
- 5 mg/1
- Pharmacologic classes
- Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Antagonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70934-835-30 | 70934083530 | 30 TABLET in 1 BOTTLE, PLASTIC (70934-835-30) | 30 tablet | 2021-03-05 | 0000-00-00 | No | No | Current |